Order Article Reprints

Uslu S, Gülle S, Sen G, Capar S, Senel S, Dalkılıc E, Akar S, Koca SS, Tufan A, Yazici A, et al. Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis. Journal of Clinical Medicine. 2024; 13(23):7266. https://doi.org/10.3390/jcm13237266

Uslu, Sadettin, Semih Gülle, Gercek Sen, Sedat Capar, Soner Senel, Ediz Dalkılıc, Servet Akar, Süleyman Serdar Koca, Abdurrahman Tufan, Ayten Yazici, and et al. 2024. "Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis" Journal of Clinical Medicine 13, no. 23: 7266. https://doi.org/10.3390/jcm13237266

Uslu, S., Gülle, S., Sen, G., Capar, S., Senel, S., Dalkılıc, E., Akar, S., Koca, S. S., Tufan, A., Yazici, A., Yilmaz, S., Inanc, N., Birlik, M., Solmaz, D., Cefle, A., Goker, B., Direskeneli, H., Yolbas, S., Steen Krogh, N., ... Sari, I. (2024). Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis. Journal of Clinical Medicine, 13(23), 7266. https://doi.org/10.3390/jcm13237266